Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Merck Says Phase 3 KEYNOTE-A39/EV-302 Trial Meets Dual Primary Endpoints

Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Friday positive topline results from the Phase 3 KEYNOTE-A39 trial, which was conducted in collaboration with Seagen Inc. (SGEN) and Astellas Pharma Inc. (ALPMY.PK, ALPMY).

RTTNews | 649 days ago

Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

Pharmaceutical companies Astellas Pharma Inc. (ALPMY.PK) and Poseida Therapeutics, Inc. (PSTX) announced Monday a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy.

RTTNews | 695 days ago

Canadian Market Down Marginally In Lackluster Trade

The Canadian market is down in negative territory in lackluster trade on Wednesday as investors largely refrain from making significant moves, choosing to wait for directional clues from the trade front.

RTTNews | 2h 7min ago

Swiss Market Closes Modestly Higher

Despite struggling for direction for much of the day's trading session, the Switzerland market closed modestly higher on Wednesday as select stocks found some good support in the final hour. The mood was cautious with investors awaiting further news on the trade front, and the data on Swiss inflation and unemployment, due later in the week.

RTTNews | 2h 36min ago

European Stocks Close Broadly Higher

European stocks closed higher on Wednesday as investors continued to closely watch trade negotiations between the U.S. and major countries across the globe ahead of the July 9 deadline for reciprocal tariffs.

RTTNews | 2h 52min ago

U.S. Private Sector Employment Unexpectedly Dips By 33,000 Jobs In June

Private sector employment in the U.S. unexpectedly decreased in the month of June, according to a report released by payroll processor ADP on Wednesday.

RTTNews | 3h 37min ago

Paramount To Pay $16 Mln To Settle Lawsuit By Trump Over Interview With Kamala Harris

Media firm Paramount Global has agreed to pay $16 million to settle a legal dispute with U.S. President Donald Trump, over its '60 Minutes' interview with former Vice President Kamala Harris, reports said. The interview was broadcast on Paramount's affiliated CBS network last year, ahead of the 2024 Presidential election.

RTTNews | 5h 57min ago

Bay Street Likely To Open With Positive Bias

Canadian shares look set to open with a positive bias on Wednesday, tracking steady European markets and higher crude oil prices. Optimism about Canada and the U.S. striking a trade deal is likely to help underpin sentiment.

RTTNews | 7h 25min ago

EURUSD	1.18032	GBPUSD	1.36351	AUDUSD	0.65877
USDJPY	143.586	USDCAD	1.35891	USDCHF	0.79125

Advertisement

Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting